通过改变SOCS1水平,SARS-CoV2感染诱导miR-155表达和歪曲Th17/Treg平衡:一项临床研究
Mohammad Sadegh Soltani-Zangbar1, Mahsa Hajivalili2, Danyal Daneshdoust3
1Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
微RNA-155 (miR-155) 在COVID-19患者中升级,影响T辅助17/调控T细胞平衡. MiR-155可以作为COVID-19严重程度的诊断和预后标志物.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 病毒学 病毒学
背景情况:
- 微RNAs (miRNAs) 在SARS-CoV2感染期间起到调节免疫反应的作用.
- miR-155是一种与炎症相关的miRNA,可能会影响COVID-19患者的免疫反应.
研究的目的:
- 研究miR-155在COVID-19中的作用.
- 在COVID-19患者中分析miR-155,T助手17 (Th17) 细胞,调节性T (Treg) 细胞和相关信号分子之间的关系.
主要方法:
- 分析了来自50名COVID-19患者和健康对照的外周血液单核细胞 (PBMC).
- 使用流式细胞计,实时PCR,西部抹杀和ELISA来评估细胞群,基因/蛋白质表达 (miR-155,SOCS-1,STAT3,FoxP3,RORγT) 和血清细胞因子水平 (IL-10,TGF-β,IL-17,IL-21).
主要成果:
- COVID-19患者的Th17细胞增加,Treg细胞减少,STAT3表达 (RNA和蛋白质) 增加.
- miR-155在COVID-19 PBMC中被上调,与SOCS-1负相关.
- 在COVID-19病例中,血清分析显示TGF-β降低,IL-17,IL-21和IL-10水平增加.
结论:
- miR-155可能会影响COVID-19中的Th17/Treg平衡.
- miR-155可能是COVID-19的潜在诊断和预后生物标志物.
更多相关视频
09:02Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions
Published on: September 22, 2023
12:08Retroviral CRISPR/Cas9-Mediated Gene Targeting for the Study of Th17 Differentiation in Vitro
Published on: November 15, 2024
相关概念视频
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
MicroRNAs
